Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Fastest Growers in Pharma
Motley Fool
Wednesday, January 25, 2012 - 5:29pm
tags:
Optimer Pharmaceuticals, Depomed, Questcor, XenoPort, Auxilium, Warner Chilcott, Hi Tech Pharmacal, ViroPharma, Salix, Endo
Trius Therapeutics plans stock offering
Yahoo/AP
Wednesday, January 25, 2012 - 5:26pm
tags:
Trius Therapeutics, stock offering
Cadence's Ofirmev Launch Is Gaining Traction
Seeking Alpha
Wednesday, January 25, 2012 - 12:39pm
tags:
Cadence Pharmaceuticals, Ofirmev, acetaminophen
Roche Patent Case Against Nova Biomedical, Lifescan Revived
Bloomberg
Wednesday, January 25, 2012 - 12:37pm
tags:
Roche, patents, Nova Biomedical, LifeScan, JNJ, glucose monitors
IPO Preview: Verastem
Seeking Alpha
Wednesday, January 25, 2012 - 12:36pm
tags:
IPOs, Verastem, Astellas, GSK, Pfizer, Sanofi
Novartis Will Pay $99 Million to Settle Overtime Lawsuit
Bloomberg
Wednesday, January 25, 2012 - 11:47am
tags:
overtime lawsuits, drug reps, Novartis
Lilly bows out of early-stage R&D joint venture with India's Jubilant
Fierce Biotech
Wednesday, January 25, 2012 - 11:11am
tags:
Eli Lilly, Jubilant, R&D, India, Vanthys Pharmaceuticals
Pharma's niche focus spurs US aid for antibiotics
Yahoo/AP
Wednesday, January 25, 2012 - 11:06am
tags:
antibiotics, R&D, innovation
Celgene Preps Q4 Report, But Investors Look Ahead
Investors.com
Wednesday, January 25, 2012 - 10:51am
tags:
earnings, Celgene
FDA Pending Catalysts For 5 Biotechs
Seeking Alpha
Wednesday, January 25, 2012 - 10:51am
tags:
FDA, Amylin, NeurogesX, Threshold Pharmaceuticals, Astex, Cell Therapeutics
Hepatitis C Pill Race Makes BioLineRx a Buyout Target: Israel Overnight
Bloomberg
Wednesday, January 25, 2012 - 10:37am
tags:
hepatitis C, BioLineRx, M&A
Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says
Bloomberg
Wednesday, January 25, 2012 - 10:34am
tags:
Pfizer, Lipitor, generics, Pharma CEOs, Watson, Paul Bisaro
Roche Offers $5.7 Billion for Illumina
Bloomberg
Wednesday, January 25, 2012 - 10:25am
tags:
Roche, Illumina, hostile bid, M&A
XenoPort says Glaxo breached Horizant contract
Reuters
Wednesday, January 25, 2012 - 10:24am
tags:
XenoPort, GSK, Horizant, RLS, restless legs syndrome
Johnson & Johnson won't restart Montco Tylenol plant until at least 2013
Philadelphia Inquirer, PA
Wednesday, January 25, 2012 - 10:24am
tags:
JNJ, Tylenol, recalls
Swiss drug maker Novartis sees Q4 profit down 47 percent to $1.2B on charges
Yahoo/AP
Wednesday, January 25, 2012 - 10:22am
tags:
Novartis, earnings
FDA Turns Down Expanded Use of Mercks’ Vytorin and Zetia
Bloomberg
Wednesday, January 25, 2012 - 9:32am
tags:
FDA, Vytorin, Merck, Zetia, kidney disease
Abbott Laboratories profit rises by 12%
Marketwatch
Wednesday, January 25, 2012 - 9:31am
tags:
earnings, Abbott Laboratories
Bristol-Myers Warning Ignored on Steroid Shots Tied to Deaths
Bloomberg
Wednesday, January 25, 2012 - 9:30am
tags:
Bristol-Myers Squibb, FDA, Kenalog
Takeda’s Daxas Fails to Win U.K. Cost Agency’s Backing
Bloomberg
Wednesday, January 25, 2012 - 9:29am
tags:
Daxas, Takeda, UK, COPD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.